The Japan Times - US panel weighs authorizing Covid vaccines for youngest children

EUR -
AED 4.178757
AFN 72.250225
ALL 94.02407
AMD 418.820541
ANG 2.037212
AOA 1043.40961
ARS 1671.167609
AUD 1.642418
AWG 2.048132
AZN 1.936314
BAM 1.952147
BBD 2.291912
BDT 139.798421
BGN 1.92397
BHD 0.429197
BIF 3399.040011
BMD 1.137851
BND 1.474142
BOB 7.880255
BRL 5.908747
BSD 1.137971
BTN 107.740405
BWP 15.474046
BYN 3.19602
BYR 22301.878658
BZD 2.288598
CAD 1.615413
CDF 2577.232365
CHF 0.921428
CLF 0.026383
CLP 1038.345585
CNY 7.708712
CNH 7.729956
COP 3924.573097
CRC 516.234068
CUC 1.137851
CUP 30.15305
CVE 110.059067
CZK 24.21597
DJF 202.640836
DKK 7.475021
DOP 66.605374
DZD 152.065763
EGP 56.57702
ERN 17.067764
ETB 183.460724
FJD 2.552029
FKP 0.858939
GBP 0.862189
GEL 3.00965
GGP 0.858939
GHS 12.7731
GIP 0.858939
GMD 83.063205
GNF 9971.342488
GTQ 8.681641
GYD 238.074536
HKD 8.921912
HNL 30.445631
HRK 7.532459
HTG 148.781613
HUF 355.564749
IDR 20387.899572
ILS 3.409366
IMP 0.858939
INR 107.767968
IQD 1490.710711
IRR 1564545.058829
ISK 144.006533
JEP 0.858939
JMD 179.124837
JOD 0.806752
JPY 183.838023
KES 147.248975
KGS 99.505233
KHR 4567.453776
KMF 490.413826
KPW 1024.066255
KRW 1745.190132
KWD 0.351562
KYD 0.948326
KZT 553.534275
LAK 25199.627175
LBP 101903.027888
LKR 380.727615
LRD 207.102488
LSL 18.764841
LTL 3.359778
LVL 0.688274
LYD 7.302337
MAD 10.650572
MDL 20.033515
MGA 4754.062829
MKD 61.631531
MMK 2388.789922
MNT 4072.368574
MOP 9.189705
MRU 45.198832
MUR 54.571616
MVR 17.590876
MWK 1973.207904
MXN 19.947221
MYR 4.711271
MZN 72.641698
NAD 18.764841
NGN 1557.364695
NIO 41.871653
NOK 11.128649
NPR 172.384449
NZD 2.003989
OMR 0.437522
PAB 1.137971
PEN 3.851992
PGK 4.990662
PHP 69.945404
PKR 316.491209
PLN 4.284179
PYG 6936.928772
QAR 4.148202
RON 5.246856
RSD 117.39894
RUB 84.778484
RWF 1668.777528
SAR 4.271824
SBD 9.176814
SCR 15.385999
SDG 683.285463
SEK 11.061152
SGD 1.475292
SHP 0.849521
SLE 28.161986
SLL 23860.169706
SOS 650.38306
SRD 42.650036
STD 23551.217393
STN 24.454243
SVC 9.957369
SYP 125.769053
SZL 18.7589
THB 37.796567
TJS 10.554451
TMT 3.993857
TND 3.368397
TOP 2.739672
TRY 52.88458
TTD 7.726543
TWD 36.010474
TZS 2986.862101
UAH 51.081221
UGX 4165.206427
USD 1.137851
UYU 45.643993
UZS 13672.237457
VES 701.90074
VND 29953.92631
VUV 135.129502
WST 3.136287
XAF 654.731922
XAG 0.018353
XAU 0.000276
XCD 3.075099
XCG 2.050863
XDR 0.812306
XOF 654.731922
XPF 119.331742
YER 271.548259
ZAR 18.797127
ZMK 10242.019498
ZMW 20.413803
ZWL 366.387542
  • CMSC

    -0.0200

    22.14

    -0.09%

  • BCC

    0.0400

    72.58

    +0.06%

  • BCE

    0.2950

    22.945

    +1.29%

  • CMSD

    -0.0600

    22.02

    -0.27%

  • RBGPF

    -0.2700

    60.34

    -0.45%

  • RYCEF

    0.2300

    18.63

    +1.23%

  • JRI

    -0.0100

    12.64

    -0.08%

  • NGG

    0.7300

    81.7

    +0.89%

  • VOD

    -0.0750

    14.045

    -0.53%

  • RIO

    -3.0200

    96.34

    -3.13%

  • GSK

    1.1200

    51.86

    +2.16%

  • RELX

    0.2600

    31.09

    +0.84%

  • BTI

    1.8250

    60.725

    +3.01%

  • BP

    -0.2650

    39.515

    -0.67%

  • AZN

    3.7800

    180.21

    +2.1%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

K.Okada--JT